RxDoctor Payments Data

Danell Brice

Psychiatric/Mental Health · Baton Rouge, LANPI 1144747387

Payments from drug & device makers

$1,428in general payments, 2019–2025

Across 77 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$286
  • AbbVie$281
  • Alkermes, Inc.$201
  • Teva Pharmaceuticals USA, Inc.$134
  • Indivior Inc.$115
  • Lundbeck LLC$104
  • plus $306 from 6 others

What the payments were for

  • Food & beverage$1,39798%
  • Education$322%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,428 in reported general payments places this provider in the 50th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana

Medicare billing

Part B allowed, 2024
$7,764
Medicare patients
30
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate55$136,725
AristadaAripiprazole Lauroxil46$136,654
VraylarCariprazine Hcl43$74,836
LybalviOlanzapine/Samidorphan Malate23$36,190
Abilify MaintenaAripiprazole12$33,649
TrintellixVortioxetine Hydrobromide32$15,545
Lurasidone Hcl43$2,859
Oxcarbazepine50$2,739
Quetiapine Fumarate225$2,425
Divalproex Sodium ErDivalproex Sodium47$2,288
Aripiprazole87$2,276
Bupropion XlBupropion Hcl112$1,941
Ziprasidone Hcl34$1,764
Buspirone Hcl165$1,716
Sertraline Hcl161$1,490

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada, Lybalvi$201$172,84369 claims
Johnson & JohnsonInvega Sustenna$53$136,72555 claims
AbbVieVraylar$281$74,83643 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$42$33,64912 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$92$15,54532 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →